Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current Deferred Tax LiabilityNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Caribou Biosciences (CRBU) Non-Current Deferred Tax Liability: 2020-2025

Historic Non-Current Deferred Tax Liability for Caribou Biosciences (CRBU) over the last 5 years, with Sep 2025 value amounting to $548,000.

  • Caribou Biosciences' Non-Current Deferred Tax Liability fell 1.62% to $548,000 in Q3 2025 from the same period last year, while for Sep 2025 it was $548,000, marking a year-over-year decrease of 1.62%. This contributed to the annual value of $548,000 for FY2024, which is 94.12% down from last year.
  • Per Caribou Biosciences' latest filing, its Non-Current Deferred Tax Liability stood at $548,000 for Q3 2025, which was down 0.00% from $548,000 recorded in Q2 2025.
  • Caribou Biosciences' 5-year Non-Current Deferred Tax Liability high stood at $10.9 million for Q4 2022, and its period low was $155,000 during Q2 2021.
  • Its 3-year average for Non-Current Deferred Tax Liability is $1.3 million, with a median of $548,000 in 2025.
  • Per our database at Business Quant, Caribou Biosciences' Non-Current Deferred Tax Liability soared by 2,043.87% in 2021 and then crashed by 94.12% in 2024.
  • Caribou Biosciences' Non-Current Deferred Tax Liability (Quarterly) stood at $3.3 million in 2021, then soared by 227.54% to $10.9 million in 2022, then fell by 14.41% to $9.3 million in 2023, then slumped by 94.12% to $548,000 in 2024, then dropped by 1.62% to $548,000 in 2025.
  • Its Non-Current Deferred Tax Liability stands at $548,000 for Q3 2025, versus $548,000 for Q2 2025 and $548,000 for Q1 2025.